NTRA
LONGINSIDER SELLNatera Inc
Research: Finviz ↗·Perplexity ↗
🗄 Viewing archived Q2 2026 data — frozen, no longer refreshed.
News Summary
PositiveNatera delivered strong operational execution with consecutive revenue beats and two upward guidance raises totaling $240M (Q2: +$100M, Q3: +$140M), while expanding gross margins and maintaining OPEX discipline. Multiple major analysts raised price targets to $430–$500 on accelerating Signatera oncology adoption, favorable regulatory tailwinds (MolDx, IVDR, Japan PMDA filing), and clinical evidence supporting MRD utility. Key ongoing investor concern remains sustained high cash burn despite profitability progress.
Red flags
- •Sustained high cash burn acknowledged by analysts as a key risk despite revenue acceleration
- •JAMA Oncology clinical data noted as not materially advancing near-term regulatory/payer catalysts
Funds Buying (3)
| Fund | Manager | Shares Held | ∆ Shares | Position Value | % of Fund | QoQ | Status |
|---|---|---|---|---|---|---|---|
| Duquesne Family Office | Stanley Druckenmiller | 3.2M | +123K | $865M | 19.9% | +4% | Existing |
| Maverick Capital | Lee Ainslie | 1.4M | +185K | $368M | 3.3% | +16% | Existing |
| Viking Global | Andreas Halvorsen | 391K | +391K | $106M | 0.3% | — | NEW |
Shares Held and Position Value reflect total quarter-end holdings. ∆ Shares is the change from the prior quarter. % of Fund is the position's share of the fund's reported equity portfolio — it drives the size weighting in the conviction score.
Portfolio Context
Where NTRA ranks in each buying fund's book, and the positions immediately around it. What a holding sits next to often says more about the thesis than the position size does.
position #1 of this fund's book
- 1Natera Inc$865M
- 2Taiwan Semiconductor Manufac$282M
- 3Stmicroelectronics N V$232M
- 4Insmed Inc$152M
position #10 of this fund's book
- 7NU HLDGS LTD$475M
- 8META PLATFORMS INC$430M
- 9GFL ENVIRONMENTAL INC$375M
- 10NATERA INC$368M
- 11TAIWAN SEMICONDUCTOR MANUFAC$340M
- 12DICKS SPORTING GOODS INC$334M
- 13MICROSOFT CORP$310M
Values are quarter-end position sizes. Shown only for funds where NTRA ranks inside their 40 largest equity positions — below that, neighbouring names carry no signal. Adjacency is an inference about a fund's reasoning, not a disclosure of it.
Signal History
| Quarter | Direction | Funds | Score | vs SPY |
|---|---|---|---|---|
| Q2 2026 | LONG | 3 | 3.90 | +6.9% |
| Q1 2026 | LONG | 3 | 3.74 | +35.3% |
Same issuer appearing in consecutive quarters — persistent institutional conviction. Returns are frozen at each archived quarter's last refresh.
Insider Activity
| Name | Title | Type | Shares | Price | Value | Filed | Src |
|---|---|---|---|---|---|---|---|
| Sheena Jonathan | — | SELL | 240 | $319.77 | $0.08M | 2026-11-11 | ↗ |
| Sheena Jonathan | — | SELL | 40 | $315.26 | $0.01M | 2026-11-11 | ↗ |
| Sheena Jonathan | — | SELL | 160 | $320.02 | $0.05M | 2026-11-11 | ↗ |
| Sheena Jonathan | — | SELL | 40 | $322.00 | $0.01M | 2026-11-11 | ↗ |
| Sheena Jonathan | — | SELL | 40 | $323.06 | $0.01M | 2026-11-11 | ↗ |
| Sheena Jonathan | — | SELL | 40 | $315.28 | $0.01M | 2026-11-11 | ↗ |
| Sheena Jonathan | — | SELL | 48 | $317.33 | $0.02M | 2026-11-11 | ↗ |
| Sheena Jonathan | — | SELL | 182 | $317.96 | $0.06M | 2026-11-11 | ↗ |
| Sheena Jonathan | — | SELL | 240 | $319.22 | $0.08M | 2026-11-11 | ↗ |
| Sheena Jonathan | — | SELL | 85 | $316.93 | $0.03M | 2026-11-11 | ↗ |
| Sheena Jonathan | — | SELL | 120 | $320.07 | $0.04M | 2026-11-11 | ↗ |
| Sheena Jonathan | — | SELL | 80 | $322.88 | $0.03M | 2026-11-11 | ↗ |
| Sheena Jonathan | — | SELL | 40 | $324.76 | $0.01M | 2026-11-11 | ↗ |
| Sheena Jonathan | — | SELL | 145 | $317.87 | $0.05M | 2026-11-11 | ↗ |
| Sheena Jonathan | — | SELL | 51 | $305.75 | $0.02M | 2026-11-06 | ↗ |
| Sheena Jonathan | — | SELL | 21 | $306.46 | $0.01M | 2026-11-06 | ↗ |
| Sheena Jonathan | — | SELL | 50 | $308.20 | $0.02M | 2026-11-06 | ↗ |
| Sheena Jonathan | — | SELL | 64 | $309.08 | $0.02M | 2026-11-06 | ↗ |
| Sheena Jonathan | — | SELL | 110 | $310.17 | $0.03M | 2026-11-06 | ↗ |
| Sheena Jonathan | — | SELL | 100 | $311.31 | $0.03M | 2026-11-06 | ↗ |
| Sheena Jonathan | — | SELL | 106 | $312.20 | $0.03M | 2026-11-06 | ↗ |
| Sheena Jonathan | — | SELL | 74 | $313.32 | $0.02M | 2026-11-06 | ↗ |
| Sheena Jonathan | — | SELL | 108 | $314.71 | $0.03M | 2026-11-06 | ↗ |
| Sheena Jonathan | — | SELL | 169 | $315.48 | $0.05M | 2026-11-06 | ↗ |
| Sheena Jonathan | — | SELL | 15 | $304.57 | $0.00M | 2026-11-06 | ↗ |
| Sheena Jonathan | — | SELL | 2K | $316.87 | $0.58M | 2026-11-06 | ↗ |
| Sheena Jonathan | — | SELL | 56 | $318.17 | $0.02M | 2026-11-06 | ↗ |
| Sheena Jonathan | — | SELL | 105 | $319.30 | $0.03M | 2026-11-06 | ↗ |
| Sheena Jonathan | — | SELL | 131 | $320.07 | $0.04M | 2026-11-06 | ↗ |
| Sheena Jonathan | — | SELL | 51 | $321.12 | $0.02M | 2026-11-06 | ↗ |
| Sheena Jonathan | — | SELL | 16 | $321.85 | $0.01M | 2026-11-06 | ↗ |
| Sheena Jonathan | — | SELL | 40 | $323.86 | $0.01M | 2026-11-06 | ↗ |
| Sheena Jonathan | — | SELL | 45 | $325.05 | $0.01M | 2026-11-06 | ↗ |
| Brophy Michael Burkes | CHIEF FINANCIAL OFFICER | SELL | 470 | $391.49 | $0.18M | 2026-11-03 | ↗ |
| Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | SELL | 408 | $408.08 | $0.17M | 2026-11-02 | ↗ |
| Sheena Jonathan | — | SELL | 3 | $388.20 | $0.00M | 2026-11-02 | ↗ |
| Sheena Jonathan | — | SELL | 109 | $400.29 | $0.04M | 2026-11-02 | ↗ |
| Rabinowitz Matthew | EXECUTIVE CHAIRMAN | SELL | 17 | $388.20 | $0.01M | 2026-11-02 | ↗ |
| Rabinowitz Matthew | EXECUTIVE CHAIRMAN | SELL | 731 | $400.29 | $0.29M | 2026-11-02 | ↗ |
| RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER | SELL | 7 | $388.20 | $0.00M | 2026-11-02 | ↗ |
| RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER | SELL | 334 | $400.29 | $0.13M | 2026-11-02 | ↗ |
| Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | SELL | 9 | $388.20 | $0.00M | 2026-11-02 | ↗ |
| Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | SELL | 410 | $400.29 | $0.16M | 2026-11-02 | ↗ |
| Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | SELL | 200 | $405.26 | $0.08M | 2026-11-02 | ↗ |
| Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | SELL | 432 | $406.94 | $0.18M | 2026-11-02 | ↗ |
| Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | SELL | 520 | $409.46 | $0.21M | 2026-11-02 | ↗ |
| Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | SELL | 120 | $410.71 | $0.05M | 2026-11-02 | ↗ |
| Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | SELL | 120 | $411.73 | $0.05M | 2026-11-02 | ↗ |
| Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | SELL | 120 | $412.88 | $0.05M | 2026-11-02 | ↗ |
| Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | SELL | 80 | $414.16 | $0.03M | 2026-11-02 | ↗ |
| Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | SELL | 760 | $415.52 | $0.32M | 2026-11-02 | ↗ |
| Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | SELL | 240 | $416.45 | $0.10M | 2026-11-02 | ↗ |
| Fesko John | PRESIDENT, CHIEF BUS. OFFICER | SELL | 7 | $388.20 | $0.00M | 2026-11-02 | ↗ |
| Fesko John | PRESIDENT, CHIEF BUS. OFFICER | SELL | 295 | $400.29 | $0.12M | 2026-11-02 | ↗ |
| Chapman Steven Leonard | CEO AND PRESIDENT | SELL | 21 | $387.90 | $0.01M | 2026-11-02 | ↗ |
| Chapman Steven Leonard | CEO AND PRESIDENT | SELL | 914 | $400.29 | $0.37M | 2026-11-02 | ↗ |
| Chapman Steven Leonard | CEO AND PRESIDENT | SELL | 3K | $415.64 | $1.19M | 2026-11-02 | ↗ |
| Brophy Michael Burkes | CHIEF FINANCIAL OFFICER | SELL | 8 | $388.03 | $0.00M | 2026-11-02 | ↗ |
| Brophy Michael Burkes | CHIEF FINANCIAL OFFICER | SELL | 317 | $400.29 | $0.13M | 2026-11-02 | ↗ |
| Brophy Michael Burkes | CHIEF FINANCIAL OFFICER | SELL | 2K | $425.55 | $0.81M | 2026-10-30 | ↗ |
| Sheena Jonathan | — | SELL | 187 | $426.34 | $0.08M | 2026-10-28 | ↗ |
| Fesko John | PRESIDENT, CHIEF BUS. OFFICER | SELL | 898 | $426.34 | $0.38M | 2026-10-28 | ↗ |
| Brophy Michael Burkes | CHIEF FINANCIAL OFFICER | SELL | 865 | $426.87 | $0.37M | 2026-10-28 | ↗ |
| Chapman Steven Leonard | CEO AND PRESIDENT | SELL | 3K | $426.34 | $1.46M | 2026-10-28 | ↗ |
| RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER | SELL | 968 | $426.34 | $0.41M | 2026-10-28 | ↗ |
| Brophy Michael Burkes | CHIEF FINANCIAL OFFICER | SELL | 1K | $426.34 | $0.51M | 2026-10-28 | ↗ |
| Brophy Michael Burkes | CHIEF FINANCIAL OFFICER | SELL | 313 | $425.32 | $0.13M | 2026-10-28 | ↗ |
| Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | SELL | 1K | $426.34 | $0.50M | 2026-10-28 | ↗ |
| Chapman Steven Leonard | CEO AND PRESIDENT | SELL | 2K | $406.00 | $0.92M | 2026-10-27 | ↗ |
| Sheena Jonathan | — | SELL | 291 | $406.00 | $0.12M | 2026-10-27 | ↗ |
| Rabinowitz Matthew | EXECUTIVE CHAIRMAN | SELL | 2K | $406.00 | $0.70M | 2026-10-27 | ↗ |
| RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER | SELL | 884 | $406.00 | $0.36M | 2026-10-27 | ↗ |
| Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | SELL | 1K | $406.00 | $0.41M | 2026-10-27 | ↗ |
| Fesko John | PRESIDENT, CHIEF BUS. OFFICER | SELL | 781 | $406.00 | $0.32M | 2026-10-27 | ↗ |
| Brophy Michael Burkes | CHIEF FINANCIAL OFFICER | SELL | 781 | $406.00 | $0.32M | 2026-10-27 | ↗ |
| Sheena Jonathan | — | SELL | 200 | $406.50 | $0.08M | 2026-10-21 | ↗ |
| Sheena Jonathan | — | SELL | 962 | $408.26 | $0.39M | 2026-10-21 | ↗ |
| Sheena Jonathan | — | SELL | 627 | $409.89 | $0.26M | 2026-10-21 | ↗ |
| Sheena Jonathan | — | SELL | 605 | $411.32 | $0.25M | 2026-10-21 | ↗ |
| Sheena Jonathan | — | SELL | 211 | $412.20 | $0.09M | 2026-10-21 | ↗ |
| Sheena Jonathan | — | SELL | 125 | $413.05 | $0.05M | 2026-10-21 | ↗ |
| Sheena Jonathan | — | SELL | 255 | $415.67 | $0.11M | 2026-10-21 | ↗ |
| Sheena Jonathan | — | SELL | 165 | $416.67 | $0.07M | 2026-10-21 | ↗ |
| Sheena Jonathan | — | SELL | 90 | $403.70 | $0.04M | 2026-10-16 | ↗ |
| Sheena Jonathan | — | SELL | 215 | $399.34 | $0.09M | 2026-10-16 | ↗ |
| Sheena Jonathan | — | SELL | 280 | $401.29 | $0.11M | 2026-10-16 | ↗ |
| Sheena Jonathan | — | SELL | 90 | $404.25 | $0.04M | 2026-10-16 | ↗ |
| Sheena Jonathan | — | SELL | 50 | $405.15 | $0.02M | 2026-10-16 | ↗ |
| Sheena Jonathan | — | SELL | 35 | $406.63 | $0.01M | 2026-10-16 | ↗ |
| Sheena Jonathan | — | SELL | 80 | $409.36 | $0.03M | 2026-10-16 | ↗ |
| Sheena Jonathan | — | SELL | 142 | $398.95 | $0.06M | 2026-10-16 | ↗ |
| Sheena Jonathan | — | SELL | 280 | $400.68 | $0.11M | 2026-10-16 | ↗ |
| Sheena Jonathan | — | SELL | 60 | $401.62 | $0.02M | 2026-10-16 | ↗ |
| Sheena Jonathan | — | SELL | 80 | $406.06 | $0.03M | 2026-10-16 | ↗ |
| Sheena Jonathan | — | SELL | 98 | $409.34 | $0.04M | 2026-10-16 | ↗ |
| Rabinowitz Matthew | EXECUTIVE CHAIRMAN | SELL | 286 | $388.32 | $0.11M | 2026-10-15 | ↗ |
| Rabinowitz Matthew | EXECUTIVE CHAIRMAN | SELL | 714 | $389.84 | $0.28M | 2026-10-15 | ↗ |
| Rabinowitz Matthew | EXECUTIVE CHAIRMAN | SELL | 600 | $390.21 | $0.23M | 2026-10-15 | ↗ |
| Rabinowitz Matthew | EXECUTIVE CHAIRMAN | SELL | 300 | $391.58 | $0.12M | 2026-10-15 | ↗ |
| Rabinowitz Matthew | EXECUTIVE CHAIRMAN | SELL | 800 | $393.47 | $0.31M | 2026-10-15 | ↗ |
| Rabinowitz Matthew | EXECUTIVE CHAIRMAN | SELL | 300 | $394.39 | $0.12M | 2026-10-15 | ↗ |
| Rabinowitz Matthew | EXECUTIVE CHAIRMAN | SELL | 2K | $396.30 | $0.75M | 2026-10-15 | ↗ |
| Rabinowitz Matthew | EXECUTIVE CHAIRMAN | SELL | 1K | $397.16 | $0.44M | 2026-10-15 | ↗ |
| Rabinowitz Matthew | EXECUTIVE CHAIRMAN | SELL | 600 | $398.09 | $0.24M | 2026-10-15 | ↗ |
| Rabinowitz Matthew | EXECUTIVE CHAIRMAN | SELL | 793 | $399.31 | $0.32M | 2026-10-15 | ↗ |
| Rabinowitz Matthew | EXECUTIVE CHAIRMAN | SELL | 3K | $400.31 | $1.07M | 2026-10-15 | ↗ |
| Rabinowitz Matthew | EXECUTIVE CHAIRMAN | SELL | 6K | $401.42 | $2.40M | 2026-10-15 | ↗ |
| Rabinowitz Matthew | EXECUTIVE CHAIRMAN | SELL | 6K | $402.23 | $2.54M | 2026-10-15 | ↗ |
| Rabinowitz Matthew | EXECUTIVE CHAIRMAN | SELL | 4K | $403.27 | $1.56M | 2026-10-15 | ↗ |
| Rabinowitz Matthew | EXECUTIVE CHAIRMAN | SELL | 10K | $404.64 | $4.18M | 2026-10-15 | ↗ |
| Rabinowitz Matthew | EXECUTIVE CHAIRMAN | SELL | 6K | $405.18 | $2.54M | 2026-10-15 | ↗ |
| Rabinowitz Matthew | EXECUTIVE CHAIRMAN | SELL | 1K | $406.63 | $0.57M | 2026-10-15 | ↗ |
| Rabinowitz Matthew | EXECUTIVE CHAIRMAN | SELL | 4K | $407.27 | $1.55M | 2026-10-15 | ↗ |
| Rabinowitz Matthew | EXECUTIVE CHAIRMAN | SELL | 2K | $408.24 | $0.82M | 2026-10-15 | ↗ |
| Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | SELL | 2K | $415.07 | $0.77M | 2026-10-01 | ↗ |
| Chapman Steven Leonard | CEO AND PRESIDENT | SELL | 1K | $413.31 | $0.53M | 2026-10-01 | ↗ |
| Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | SELL | 200 | $411.62 | $0.08M | 2026-10-01 | ↗ |
| Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | SELL | 954 | $413.11 | $0.39M | 2026-10-01 | ↗ |
| Sheena Jonathan | — | SELL | 1K | $388.71 | $0.50M | 2026-09-23 | ↗ |
| Sheena Jonathan | — | SELL | 3K | $387.65 | $1.06M | 2026-09-23 | ↗ |
| Sheena Jonathan | — | SELL | 2K | $386.71 | $0.84M | 2026-09-23 | ↗ |
| Sheena Jonathan | — | SELL | 400 | $385.10 | $0.15M | 2026-09-23 | ↗ |
| Sheena Jonathan | — | SELL | 2K | $389.69 | $0.90M | 2026-09-23 | ↗ |
| Sheena Jonathan | — | SELL | 110 | $390.42 | $0.04M | 2026-09-23 | ↗ |
| Sheena Jonathan | — | SELL | 390 | $385.29 | $0.15M | 2026-09-23 | ↗ |
| Sheena Jonathan | — | SELL | 2K | $386.64 | $0.89M | 2026-09-23 | ↗ |
| Sheena Jonathan | — | SELL | 3K | $387.74 | $1.10M | 2026-09-23 | ↗ |
| Sheena Jonathan | — | SELL | 1K | $388.76 | $0.52M | 2026-09-23 | ↗ |
| Sheena Jonathan | — | SELL | 2K | $389.71 | $0.75M | 2026-09-23 | ↗ |
| Sheena Jonathan | — | SELL | 220 | $390.52 | $0.09M | 2026-09-23 | ↗ |
| Sheena Jonathan | — | SELL | 800 | $355.95 | $0.28M | 2026-09-16 | ↗ |
| Sheena Jonathan | — | SELL | 200 | $348.02 | $0.07M | 2026-09-16 | ↗ |
| Sheena Jonathan | — | SELL | 100 | $349.05 | $0.03M | 2026-09-16 | ↗ |
| Sheena Jonathan | — | SELL | 1K | $353.83 | $0.50M | 2026-09-16 | ↗ |
| Sheena Jonathan | — | SELL | 450 | $354.91 | $0.16M | 2026-09-16 | ↗ |
| Sheena Jonathan | — | SELL | 200 | $356.87 | $0.07M | 2026-09-16 | ↗ |
| Rabinowitz Matthew | EXECUTIVE CHAIRMAN | SELL | 3K | $347.81 | $0.94M | 2026-09-15 | ↗ |
| Sheena Jonathan | — | SELL | 6K | $350.07 | $2.10M | 2026-09-15 | ↗ |
| Rabinowitz Matthew | EXECUTIVE CHAIRMAN | SELL | 1K | $339.24 | $0.50M | 2026-09-15 | ↗ |
| Rabinowitz Matthew | EXECUTIVE CHAIRMAN | SELL | 3K | $340.25 | $0.87M | 2026-09-15 | ↗ |
| Rabinowitz Matthew | EXECUTIVE CHAIRMAN | SELL | 2K | $341.41 | $0.62M | 2026-09-15 | ↗ |
| Rabinowitz Matthew | EXECUTIVE CHAIRMAN | SELL | 2K | $342.18 | $0.67M | 2026-09-15 | ↗ |
| Rabinowitz Matthew | EXECUTIVE CHAIRMAN | SELL | 2K | $343.56 | $0.77M | 2026-09-15 | ↗ |
| Rabinowitz Matthew | EXECUTIVE CHAIRMAN | SELL | 6K | $344.49 | $2.01M | 2026-09-15 | ↗ |
| Rabinowitz Matthew | EXECUTIVE CHAIRMAN | SELL | 3K | $345.38 | $0.93M | 2026-09-15 | ↗ |
| Rabinowitz Matthew | EXECUTIVE CHAIRMAN | SELL | 1K | $346.68 | $0.39M | 2026-09-15 | ↗ |
| Rabinowitz Matthew | EXECUTIVE CHAIRMAN | SELL | 8K | $348.65 | $2.82M | 2026-09-15 | ↗ |
| Rabinowitz Matthew | EXECUTIVE CHAIRMAN | SELL | 4K | $349.51 | $1.47M | 2026-09-15 | ↗ |
| Rabinowitz Matthew | EXECUTIVE CHAIRMAN | SELL | 15K | $350.81 | $5.09M | 2026-09-15 | ↗ |
| Rabinowitz Matthew | EXECUTIVE CHAIRMAN | SELL | 800 | $351.25 | $0.28M | 2026-09-15 | ↗ |
| Rabinowitz Matthew | EXECUTIVE CHAIRMAN | SELL | 2K | $350.01 | $0.70M | 2026-09-15 | ↗ |
| Rabinowitz Matthew | EXECUTIVE CHAIRMAN | SELL | 3K | $341.35 | $0.92M | 2026-09-14 | ↗ |
| Rabinowitz Matthew | EXECUTIVE CHAIRMAN | SELL | 2K | $328.09 | $0.50M | 2026-09-14 | ↗ |
| Rabinowitz Matthew | EXECUTIVE CHAIRMAN | SELL | 4K | $335.18 | $1.26M | 2026-09-14 | ↗ |
| Rabinowitz Matthew | EXECUTIVE CHAIRMAN | SELL | 8K | $336.27 | $2.84M | 2026-09-14 | ↗ |
| Rabinowitz Matthew | EXECUTIVE CHAIRMAN | SELL | 2K | $337.17 | $0.74M | 2026-09-14 | ↗ |
| Rabinowitz Matthew | EXECUTIVE CHAIRMAN | SELL | 1K | $338.30 | $0.47M | 2026-09-14 | ↗ |
| Rabinowitz Matthew | EXECUTIVE CHAIRMAN | SELL | 2K | $339.37 | $0.71M | 2026-09-14 | ↗ |
| Rabinowitz Matthew | EXECUTIVE CHAIRMAN | SELL | 2K | $340.31 | $0.68M | 2026-09-14 | ↗ |
| Rabinowitz Matthew | EXECUTIVE CHAIRMAN | SELL | 4K | $342.51 | $1.39M | 2026-09-14 | ↗ |
| Rabinowitz Matthew | EXECUTIVE CHAIRMAN | SELL | 6K | $329.12 | $1.98M | 2026-09-14 | ↗ |
| Rabinowitz Matthew | EXECUTIVE CHAIRMAN | SELL | 6K | $330.05 | $2.05M | 2026-09-14 | ↗ |
| Rabinowitz Matthew | EXECUTIVE CHAIRMAN | SELL | 3K | $330.98 | $1.16M | 2026-09-14 | ↗ |
| Rabinowitz Matthew | EXECUTIVE CHAIRMAN | SELL | 1K | $332.02 | $0.33M | 2026-09-14 | ↗ |
| Rabinowitz Matthew | EXECUTIVE CHAIRMAN | SELL | 2K | $333.07 | $0.75M | 2026-09-14 | ↗ |
| Rabinowitz Matthew | EXECUTIVE CHAIRMAN | SELL | 3K | $334.24 | $0.94M | 2026-09-14 | ↗ |
| Rabinowitz Matthew | EXECUTIVE CHAIRMAN | SELL | 1K | $329.62 | $0.43M | 2026-09-11 | ↗ |
| Rabinowitz Matthew | EXECUTIVE CHAIRMAN | SELL | 18K | $327.97 | $5.88M | 2026-09-11 | ↗ |
| Rabinowitz Matthew | EXECUTIVE CHAIRMAN | SELL | 16K | $328.95 | $5.19M | 2026-09-11 | ↗ |
| Rabinowitz Matthew | EXECUTIVE CHAIRMAN | SELL | 11K | $327.14 | $3.45M | 2026-09-11 | ↗ |
| Rabinowitz Matthew | EXECUTIVE CHAIRMAN | SELL | 4K | $326.11 | $1.19M | 2026-09-11 | ↗ |
| Rabinowitz Matthew | EXECUTIVE CHAIRMAN | SELL | 800 | $325.01 | $0.26M | 2026-09-11 | ↗ |
| Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | SELL | 15K | $326.89 | $4.96M | 2026-09-02 | ↗ |
| Chapman Steven Leonard | CEO AND PRESIDENT | SELL | 2K | $320.99 | $0.55M | 2026-09-01 | ↗ |
| Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | SELL | 1K | $319.76 | $0.32M | 2026-09-01 | ↗ |
| Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | SELL | 1K | $320.92 | $0.45M | 2026-09-01 | ↗ |
| Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | SELL | 600 | $321.91 | $0.19M | 2026-09-01 | ↗ |
| Fesko John | PRESIDENT, CHIEF BUS. OFFICER | SELL | 7K | $321.53 | $2.10M | 2026-08-10 | ↗ |
| Sheena Jonathan | — | SELL | 6K | $325.32 | $1.95M | 2026-08-10 | ↗ |
| Sheena Jonathan | — | SELL | 600 | $315.32 | $0.19M | 2026-08-07 | ↗ |
| Sheena Jonathan | — | SELL | 5K | $316.61 | $1.62M | 2026-08-07 | ↗ |
| Sheena Jonathan | — | SELL | 200 | $317.96 | $0.06M | 2026-08-07 | ↗ |
| Sheena Jonathan | — | SELL | 100 | $318.63 | $0.03M | 2026-08-07 | ↗ |
| Sheena Jonathan | — | SELL | 489 | $320.90 | $0.16M | 2026-08-07 | ↗ |
| Sheena Jonathan | — | SELL | 400 | $311.88 | $0.12M | 2026-08-07 | ↗ |
| Sheena Jonathan | — | SELL | 850 | $314.25 | $0.27M | 2026-08-07 | ↗ |
| Sheena Jonathan | — | SELL | 900 | $313.07 | $0.28M | 2026-08-07 | ↗ |
| Rabinowitz Matthew | EXECUTIVE CHAIRMAN | SELL | 2K | $320.90 | $0.64M | 2026-08-07 | ↗ |
| Sheena Jonathan | — | SELL | 100 | $308.40 | $0.03M | 2026-08-07 | ↗ |
| Sheena Jonathan | — | SELL | 400 | $310.23 | $0.12M | 2026-08-07 | ↗ |
| Brophy Michael Burkes | CHIEF FINANCIAL OFFICER | SELL | 478 | $274.22 | $0.13M | 2026-08-04 | ↗ |
| Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | SELL | 1K | $267.79 | $0.33M | 2026-08-03 | ↗ |
| Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | SELL | 128 | $268.70 | $0.03M | 2026-08-03 | ↗ |
| RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER | SELL | 334 | $267.99 | $0.09M | 2026-08-03 | ↗ |
| Rabinowitz Matthew | EXECUTIVE CHAIRMAN | SELL | 731 | $267.99 | $0.20M | 2026-08-03 | ↗ |
| Sheena Jonathan | — | SELL | 109 | $267.99 | $0.03M | 2026-08-03 | ↗ |
| Chapman Steven Leonard | CEO AND PRESIDENT | SELL | 612 | $268.22 | $0.16M | 2026-08-03 | ↗ |
| Brophy Michael Burkes | CHIEF FINANCIAL OFFICER | SELL | 317 | $267.99 | $0.08M | 2026-08-03 | ↗ |
| Chapman Steven Leonard | CEO AND PRESIDENT | SELL | 1K | $267.99 | $0.32M | 2026-08-03 | ↗ |
| Chapman Steven Leonard | CEO AND PRESIDENT | SELL | 160 | $259.98 | $0.04M | 2026-08-03 | ↗ |
| Chapman Steven Leonard | CEO AND PRESIDENT | SELL | 70 | $261.02 | $0.02M | 2026-08-03 | ↗ |
| Chapman Steven Leonard | CEO AND PRESIDENT | SELL | 676 | $263.86 | $0.18M | 2026-08-03 | ↗ |
| Chapman Steven Leonard | CEO AND PRESIDENT | SELL | 80 | $265.27 | $0.02M | 2026-08-03 | ↗ |
| Chapman Steven Leonard | CEO AND PRESIDENT | SELL | 296 | $267.08 | $0.08M | 2026-08-03 | ↗ |
| Fesko John | PRESIDENT, CHIEF BUS. OFFICER | SELL | 295 | $267.99 | $0.08M | 2026-08-03 | ↗ |
| Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | SELL | 410 | $267.99 | $0.11M | 2026-08-03 | ↗ |
| Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | SELL | 300 | $259.98 | $0.08M | 2026-08-03 | ↗ |
| Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | SELL | 200 | $261.49 | $0.05M | 2026-08-03 | ↗ |
| Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | SELL | 947 | $263.94 | $0.25M | 2026-08-03 | ↗ |
| Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | SELL | 192 | $265.27 | $0.05M | 2026-08-03 | ↗ |
| Brophy Michael Burkes | CHIEF FINANCIAL OFFICER | SELL | 2K | $249.38 | $0.46M | 2026-07-29 | ↗ |
| Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | SELL | 1K | $254.07 | $0.31M | 2026-07-28 | ↗ |
| Brophy Michael Burkes | CHIEF FINANCIAL OFFICER | SELL | 1K | $254.07 | $0.32M | 2026-07-28 | ↗ |
| Brophy Michael Burkes | CHIEF FINANCIAL OFFICER | SELL | 1K | $253.77 | $0.26M | 2026-07-28 | ↗ |
| Brophy Michael Burkes | CHIEF FINANCIAL OFFICER | SELL | 170 | $254.33 | $0.04M | 2026-07-28 | ↗ |
| RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER | SELL | 1K | $254.07 | $0.25M | 2026-07-28 | ↗ |
| Fesko John | PRESIDENT, CHIEF BUS. OFFICER | SELL | 931 | $254.07 | $0.24M | 2026-07-28 | ↗ |
| Chapman Steven Leonard | CEO AND PRESIDENT | SELL | 4K | $254.07 | $0.91M | 2026-07-28 | ↗ |
| Sheena Jonathan | — | SELL | 191 | $254.07 | $0.05M | 2026-07-28 | ↗ |
| Sheena Jonathan | — | SELL | 288 | $260.49 | $0.08M | 2026-07-27 | ↗ |
| RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER | SELL | 884 | $260.49 | $0.23M | 2026-07-27 | ↗ |
| Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | SELL | 1K | $260.49 | $0.26M | 2026-07-27 | ↗ |
| Fesko John | PRESIDENT, CHIEF BUS. OFFICER | SELL | 782 | $260.49 | $0.20M | 2026-07-27 | ↗ |
| Chapman Steven Leonard | CEO AND PRESIDENT | SELL | 2K | $260.49 | $0.57M | 2026-07-27 | ↗ |
| Brophy Michael Burkes | CHIEF FINANCIAL OFFICER | SELL | 782 | $260.49 | $0.20M | 2026-07-27 | ↗ |
| Sheena Jonathan | — | SELL | 450 | $273.05 | $0.12M | 2026-07-15 | ↗ |
| Sheena Jonathan | — | SELL | 90 | $274.26 | $0.02M | 2026-07-15 | ↗ |
| Sheena Jonathan | — | SELL | 170 | $275.26 | $0.05M | 2026-07-15 | ↗ |
| Sheena Jonathan | — | SELL | 40 | $276.38 | $0.01M | 2026-07-15 | ↗ |
| Sheena Jonathan | — | SELL | 390 | $273.01 | $0.11M | 2026-07-15 | ↗ |
| Sheena Jonathan | — | SELL | 100 | $273.68 | $0.03M | 2026-07-15 | ↗ |
| Sheena Jonathan | — | SELL | 180 | $274.99 | $0.05M | 2026-07-15 | ↗ |
| Sheena Jonathan | — | SELL | 80 | $276.01 | $0.02M | 2026-07-15 | ↗ |
| Chapman Rowan E | — | SELL | 135 | $274.82 | $0.04M | 2026-07-15 | ↗ |
Beneficial Ownership (13D/13G)
| Filer | Form | Shares | % of Class | Filed | Src |
|---|---|---|---|---|---|
| FMR LLC | SC 13G/A | 15.1M | 10.5% | 2026-11-06 | ↗ |
| FMR LLC | SC 13G | 13.7M | 9.5% | 2026-11-05 | ↗ |
| T. Rowe Price Associates, Inc. | SC 13G/A | 9.0M | 6.3% | 2026-08-14 | ↗ |
| Vanguard Capital Management | SC 13G | 7.2M | 5.1% | 2026-04-30 | ↗ |
SC 13D = active intent to influence control (10-day filing deadline after crossing 5%). SC 13G = passive accumulation, no intent to influence control.